Showing results (541-550 of 3,540) with videos related to
Sort By:
Pageof 354
Chemical Biology & Drug Design|July 28, 2015
Molecular Modeling, Synthesis, and Anti-HIV Activity of Novel Isoindolinedione Analogues as Potent Non-nucleoside Reverse Transcriptase InhibitorsGarima Kumari, Ramendra K SinghChemical Biology & Drug Design|August 18, 2017
Comparative in vitro study on cytotoxicity of recombinant β-hairpin peptidesDenis V Kuzmin, Anna A Emelianova, Mariana B Kalashnikova, et al.Chemical Biology & Drug Design|August 18, 2017
The discovery of new and more potent chloropyramine (C4) analogues for the potential treatment of invasive breast cancerSahar Kandil, Filippo Prencipe, Samuel Jones, et al.Chemical Biology & Drug Design|August 18, 2017
Docking field-based QSAR and pharmacophore studies on the substituted pyrimidine derivatives targeting HIV-1 reverse transcriptaseNingning Fan, Shuang Zhang, Tao Sheng, et al.Chemical Biology & Drug Design|March 26, 2018
Discovery of novel pyrrolopyrimidine/pyrazolopyrimidine derivatives bearing 1,2,3-triazole moiety as c-Met kinase inhibitorsLinxiao Wang, Xiaobo Liu, Yongli Duan, et al.Chemical Biology & Drug Design|February 7, 2018
1,2,3,4-Tetrahydroisoquinolines as inhibitors of HIV-1 integrase and human LEDGF/p75 interactionAnu George, Alavala Gopi Krishna Reddy, Gedu Satyanarayana, et al.Chemical Biology & Drug Design|August 24, 2017
Lipophilic conformationally constrained spiro carbocyclic 2,6-diketopiperazine-1-acetohydroxamic acid analogues as trypanocidal and leishmanicidal agents: An extended SAR studyGrigoris Zoidis, Andrew Tsotinis, Alexandra Tsatsaroni, et al.Chemical Biology & Drug Design|August 24, 2017
Sofosbuvir as treatment against dengue?Chye Sheng Gan, See Khai Lim, Chin Fei Chee, et al.Chemical Biology & Drug Design|January 17, 2018
Insight into the inhibitor discrimination by FLT3 F691LSharad Verma, Aditi Singh, Anchala Kumari, et al.Chemical Biology & Drug Design|February 2, 2018
A novel class of human 15-LOX-1 inhibitors based on 3-hydroxycoumarinSeyed Jamal Alavi, Hamid Sadeghian, Seyed Mohammad Seyedi, et al.Pageof 354